Does LOVASTATIN Cause Type iia hyperlipidaemia? 56 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 56 reports of Type iia hyperlipidaemia have been filed in association with LOVASTATIN (Lovastatin). This represents 4.0% of all adverse event reports for LOVASTATIN.
56
Reports of Type iia hyperlipidaemia with LOVASTATIN
4.0%
of all LOVASTATIN reports
55
Deaths
12
Hospitalizations
How Dangerous Is Type iia hyperlipidaemia From LOVASTATIN?
Of the 56 reports, 55 (98.2%) resulted in death, 12 (21.4%) required hospitalization.
Is Type iia hyperlipidaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LOVASTATIN. However, 56 reports have been filed with the FAERS database.
What Other Side Effects Does LOVASTATIN Cause?
Drug hypersensitivity (217)
Myalgia (192)
Drug ineffective (137)
Completed suicide (91)
Muscle spasms (91)
Cerebrovascular accident (81)
Myocardial infarction (71)
Asthenia (67)
Arthralgia (63)
Disease progression (59)
What Other Drugs Cause Type iia hyperlipidaemia?
ATORVASTATIN (67)
EZETIMIBE (67)
EVOLOCUMAB (66)
ROSUVASTATIN (63)
SIMVASTATIN (63)
LOMITAPIDE (59)
PROBUCOL (56)
IMPLITAPIDE (49)
CAFFEINE\PROCAINE (10)
TOCILIZUMAB (8)
Which LOVASTATIN Alternatives Have Lower Type iia hyperlipidaemia Risk?
LOVASTATIN vs LOVAZA
LOVASTATIN vs LOVENOX
LOVASTATIN vs LOXAPINE
LOVASTATIN vs LOXOPROFEN
LOVASTATIN vs LUBIPROSTONE